Obesity-associated alterations in cardiac connexin-43 and PKC signaling are attenuated by melatonin and omega-3 fatty acids in female rats.


Journal

Molecular and cellular biochemistry
ISSN: 1573-4919
Titre abrégé: Mol Cell Biochem
Pays: Netherlands
ID NLM: 0364456

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 18 06 2018
accepted: 17 10 2018
pubmed: 18 11 2018
medline: 20 4 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

We aimed to explore whether specific high-sucrose intake in older female rats affects myocardial electrical coupling protein, connexin-43 (Cx43), protein kinase C (PKC) signaling, miR-1 and miR-30a expression, and susceptibility of the heart to malignant arrhythmias. Possible benefit of the supplementation with melatonin (40 µg/ml/day) and omega-3 polyunsaturated fatty acids (Omacor, 25 g/kg of rat chow) was examined as well. Results have shown that 8 weeks lasting intake of 30% sucrose solution increased serum cholesterol, triglycerides, body weight, heart weight, and retroperitoneal adipose tissues. It was accompanied by downregulation of cardiac Cx43 and PKCε signaling along with an upregulation of myocardial PKCδ and miR-30a rendering the heart prone to ventricular arrhythmias. There was a clear benefit of melatonin or omega-3 PUFA supplementation due to their antiarrhythmic effects associated with the attenuation of myocardial Cx43, PKC, and miR-30a abnormalities as well as adiposity. The potential impact of these findings may be considerable, and suggests that high-sucrose intake impairs myocardial signaling mediated by Cx43 and PKC contributing to increased susceptibility of the older obese female rat hearts to malignant arrhythmias.

Identifiants

pubmed: 30446908
doi: 10.1007/s11010-018-3463-0
pii: 10.1007/s11010-018-3463-0
doi:

Substances chimiques

Anti-Arrhythmia Agents 0
Connexin 43 0
Dietary Sucrose 0
Fatty Acids, Omega-3 0
MIRN30 microRNA, rat 0
MicroRNAs 0
Protein Kinase C-delta EC 2.7.11.13
Protein Kinase C-epsilon EC 2.7.11.13
Melatonin JL5DK93RCL

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-202

Subventions

Organisme : Agentúra na Podporu Výskumu a Vývoja
ID : APVV-15-0119
Organisme : Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
ID : 2/0167/15
Organisme : Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
ID : 2/0076/16
Organisme : EU Structural Fund ITMS
ID : 26230120006

Références

Obes Res. 2000 Jan;8(1):20-8
pubmed: 10678255
Circ Res. 2000 Feb 18;86(3):293-301
pubmed: 10679481
Cardiovasc Res. 2000 Jul;47(1):108-15
pubmed: 10869536
J Cell Mol Med. 2001 Oct-Dec;5(4):355-66
pubmed: 12067469
Circulation. 2003 Jun 3;107(21):2646-52
pubmed: 12782616
Am J Physiol Heart Circ Physiol. 2004 May;286(5):H2001-9
pubmed: 14704225
Biochem J. 2004 Dec 15;384(Pt 3):449-59
pubmed: 15491280
Circ Res. 2004 Nov 12;95(10):1035-41
pubmed: 15499029
Heart Rhythm. 2006 Jan;3(1):102-7
pubmed: 16399064
Exp Biol Med (Maywood). 2006 Apr;231(4):473-84
pubmed: 16565443
J Pineal Res. 2007 Jan;42(1):55-63
pubmed: 17198539
Nat Med. 2007 Apr;13(4):486-91
pubmed: 17401374
Neuro Endocrinol Lett. 2007 Apr;28(2):159-65
pubmed: 17435669
Front Neuroendocrinol. 2007 Aug-Sep;28(2-3):61-71
pubmed: 17451793
J Cardiovasc Med (Hagerstown). 2007 Sep;8 Suppl 1:S46-9
pubmed: 17876200
Physiol Res. 2008;57 Suppl 2:S39-48
pubmed: 18373394
J Physiol Pharmacol. 2008 Jun;59(2):271-85
pubmed: 18622045
Circ Res. 2009 Jan 30;104(2):170-8, 6p following 178
pubmed: 19096030
J Am Coll Cardiol. 2009 May 26;53(21):1925-32
pubmed: 19460605
Mol Cell Biochem. 2009 Dec;332(1-2):145-59
pubmed: 19536638
Naunyn Schmiedebergs Arch Pharmacol. 2010 Mar;381(3):221-34
pubmed: 19943035
J Appl Physiol (1985). 2010 Apr;108(4):933-40
pubmed: 20133431
Circ Res. 2010 Feb 19;106(3):447-62
pubmed: 20167942
J Pineal Res. 2010 Nov;49(4):364-72
pubmed: 20738756
Biochim Biophys Acta. 2012 Aug;1818(8):2009-13
pubmed: 21763271
Acta Physiol (Oxf). 2012 Jun;205(2):209-23
pubmed: 22226301
Exp Clin Cardiol. 2012 Summer;17(2):84-7
pubmed: 22826655
PLoS One. 2013;8(1):e53950
pubmed: 23326547
Cardiovasc Diabetol. 2013 Jan 24;12:23
pubmed: 23347533
Circ Arrhythm Electrophysiol. 2013 Jun;6(3):623-31
pubmed: 23559673
J Pineal Res. 2013 Sep;55(2):166-73
pubmed: 23635352
J Hypertens. 2013 Sep;31(9):1876-85
pubmed: 23719203
Compr Physiol. 2012 Jul;2(3):1981-2035
pubmed: 23723031
Can J Physiol Pharmacol. 2013 Aug;91(8):633-9
pubmed: 23889002
J Pineal Res. 2014 May;56(4):371-81
pubmed: 24654916
Thorac Cardiovasc Surg. 2014 Oct;62(7):547-53
pubmed: 24715526
Obes Rev. 2014 Aug;15(8):657-65
pubmed: 24891155
Endocr Metab Immune Disord Drug Targets. 2014;14(3):159-68
pubmed: 24934925
Horm Metab Res. 2015 Jun;47(7):504-8
pubmed: 25126957
Physiol Res. 2015;64(3):433-8
pubmed: 25536315
Can J Cardiol. 2015 Feb;31(2):203-10
pubmed: 25661555
J Physiol Pharmacol. 2015 Feb;66(1):83-9
pubmed: 25716968
J Electrocardiol. 2015 May-Jun;48(3):434-40
pubmed: 25732099
Eur Rev Med Pharmacol Sci. 2015 May;19(10):1915-21
pubmed: 26044240
Circ Res. 2015 Jun 5;116(12):1937-55
pubmed: 26044249
Eur Heart J. 2016 May 21;37(20):1565-72
pubmed: 26371114
J Physiol Pharmacol. 2015 Oct;66(5):625-34
pubmed: 26579568
Cardiovasc Res. 2016 Apr 1;109(4):502-9
pubmed: 26790475
J Pineal Res. 2016 Oct;61(3):253-78
pubmed: 27500468
Circulation. 2017 May 9;135(19):e1017-e1034
pubmed: 27550974
Histochem Cell Biol. 2017 Jan;147(1):63-73
pubmed: 27600718
Am J Cardiol. 2016 Nov 15;118(10):1486-1492
pubmed: 27666172
J Pineal Res. 2017 May;62(4):null
pubmed: 28199741
J Atr Fibrillation. 2013 Feb 12;5(5):676
pubmed: 28496808
Int J Mol Med. 2017 Jul;40(1):217-225
pubmed: 28498436
J Mol Cell Cardiol. 2017 Oct;111:96-101
pubmed: 28822806
Nutrients. 2017 Oct 30;9(11):null
pubmed: 29084142

Auteurs

Tamara Egan Benova (T)

Center of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Dúbravská cesta 9, 841 04, Bartislava, Slovakia.

Csilla Viczenczova (C)

Center of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Dúbravská cesta 9, 841 04, Bartislava, Slovakia.

Barbara Szeiffova Bacova (B)

Center of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Dúbravská cesta 9, 841 04, Bartislava, Slovakia.

Vladimir Knezl (V)

Center of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia.

Victor Dosenko (V)

State Key Laboratory of Molecular and Cellular Biology, Bogomoletz Institute of Physiology, Kyiv, Ukraine.

Hana Rauchova (H)

Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.

Michal Zeman (M)

Department of Animal Physiology and Ethology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia.

Russel J Reiter (RJ)

Department of Cellular and Structural Biology, UT Health Science Center, San Antonio, 78229, TX, USA.

Narcis Tribulova (N)

Center of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Dúbravská cesta 9, 841 04, Bartislava, Slovakia. narcisa.tribulova@savba.sk.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH